These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 24994473)
1. Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells. Jendželovská Z; Jendželovský R; Hiľovská L; Kovaľ J; Mikeš J; Fedoročko P Toxicol In Vitro; 2014 Oct; 28(7):1259-73. PubMed ID: 24994473 [TBL] [Abstract][Full Text] [Related]
2. Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells. Jendzelovský R; Mikes J; Koval' J; Soucek K; Procházková J; Kello M; Sacková V; Hofmanová J; Kozubík A; Fedorocko P Photochem Photobiol Sci; 2009 Dec; 8(12):1716-23. PubMed ID: 20024169 [TBL] [Abstract][Full Text] [Related]
3. Hypericin affects cancer side populations via competitive inhibition of BCRP. Vargová J; Mikeš J; Jendželovský R; Mikešová L; Kuchárová B; Čulka Ľ; Fedr R; Remšík J; Souček K; Kozubík A; Fedoročko P Biomed Pharmacother; 2018 Mar; 99():511-522. PubMed ID: 29665654 [TBL] [Abstract][Full Text] [Related]
4. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of BCRP and anti-apoptotic proteins by proadifen (SKF-525A) is responsible for the enhanced mitoxantrone accumulation and toxicity in mitoxantrone-resistant human promyelocytic leukemia cells. Hiľovská L; Jendželovský R; Jendželovská Z; Kovaľ J; Fedoročko P Int J Oncol; 2015 Oct; 47(4):1572-84. PubMed ID: 26252082 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques. Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006 [TBL] [Abstract][Full Text] [Related]
7. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line. Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377 [TBL] [Abstract][Full Text] [Related]
8. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum). Peebles KA; Baker RK; Kurz EU; Schneider BJ; Kroll DJ Biochem Pharmacol; 2001 Oct; 62(8):1059-70. PubMed ID: 11597574 [TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy. Jendželovský R; Jendželovská Z; Kuchárová B; Fedoročko P Biomed Pharmacother; 2019 Jan; 109():2173-2181. PubMed ID: 30551474 [TBL] [Abstract][Full Text] [Related]
11. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells]. Zhang YH; Li G; Yu J; Xu MS; Liu ZX Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044 [TBL] [Abstract][Full Text] [Related]
12. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. Hostanska K; Reichling J; Bommer S; Weber M; Saller R Eur J Pharm Biopharm; 2003 Jul; 56(1):121-32. PubMed ID: 12837490 [TBL] [Abstract][Full Text] [Related]
13. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1. Wang TH; Wan JY; Gong X; Li HZ; Cheng Y Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2. Kowalski P; Stein U; Scheffer GL; Lage H Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of hepatocellular toxicity associated with the components of St. John's Wort extract hypericin and hyperforin in HepG2 and HepaRG cells. Abegg VF; Panajatovic MV; Mancuso RV; Allard JA; Duthaler U; Odermatt A; Krähenbühl S; Bouitbir J Toxicol Lett; 2024 Mar; 393():1-13. PubMed ID: 38219807 [TBL] [Abstract][Full Text] [Related]
17. Accumulation and photodynamic activity of chlorin e6 in cisplatin-resistant human lung cancer cells. Horibe S; Nagai J; Yumoto R; Tawa R; Takano M J Pharm Sci; 2011 Jul; 100(7):3010-7. PubMed ID: 21274848 [TBL] [Abstract][Full Text] [Related]
18. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin. Wang EJ; Barecki-Roach M; Johnson WW J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009 [TBL] [Abstract][Full Text] [Related]
19. ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells. Mirzaei SA; Gholamian Dehkordi N; Ghamghami M; Amiri AH; Dalir Abdolahinia E; Elahian F Toxicol Appl Pharmacol; 2017 Dec; 337():22-29. PubMed ID: 29079042 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]